Canada markets closed

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.12-0.17 (-0.40%)
At close: 04:00PM EDT
42.12 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
4,013
4,013
4,737
1,078
0
Operating Expenses
Research Development
168,527
168,527
130,225
84,255
56,998
Selling General and Administrative
58,094
58,094
42,394
24,525
18,026
Total Operating Expenses
226,621
226,621
172,619
108,780
74,953
Operating Income or Loss
-222,608
-222,608
-167,882
-107,702
-74,953
Total Other Income/Expenses Net
-5,357
-5,357
-353
-96
150
Income Before Tax
-214,529
-214,529
-163,918
-107,641
-73,812
Income from Continuing Operations
-214,529
-214,529
-163,918
-107,641
-73,812
Net Income
-214,529
-214,529
-163,918
-107,641
-73,812
Net Income available to common shareholders
-214,529
-214,529
-163,918
-107,641
-73,812
Basic EPS
-3.64
-3.69
-3.15
-2.80
-2.42
Diluted EPS
-3.64
-3.69
-3.15
-2.80
-2.42
Basic Average Shares
54,717
58,071
51,982
38,436
30,448
Diluted Average Shares
54,717
58,071
51,982
38,436
30,448